Bruce J. Kinon - Concepedia

Author

Bruce J. Kinon

Also Known As

B J Kinon, B KINON, B Kinon, B. J. Kinon, B. Kinon, B.J. Kinon, BRUCE J. KINON, BRUCE KINON, Bruce J Kinon, Bruce J. Kinon

201

Publications

10.5K

Citations

H-Index

Concepts

All Affiliations

Eli Lilly (United States)King's College London Lundbeck (United States)Zucker Hillside Hospital Lundbeck (Denmark)

About

Bruce J. Kinon is an author at Eli Lilly (United States) specializing in medicine, psychiatry, and psychopathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	36	59	3.8K
2	Health Sciences	2	2	40
3	Engineering	1	1	16
4	Natural Sciences	1	1	125
5	Nursing	1	1	83

Bruce J. Kinon

102

Publications

7.5K

Citations

H-Index

Page 1

	Year	Citations
Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs Miranda Chakos, J.A. Lieberman, Robert M. Bilder, American Journal of Psychiatry	1994	564
Prevalence of hyperprolactinemia in schizophrenic patients treated with conventional antipsychotic medications or risperidone Bruce J. Kinon, J. A. Gilmore, Hong Liu, Psychoneuroendocrinology	2003	346
Long-term olanzapine treatment: weight change and weight-related health factors in schizophrenia. Bruce J. Kinon, Bruce R. Basson, J. A. Gilmore, PubMed	2001	319
Factors Influencing Acute Weight Change in Patients With Schizophrenia Treated With Olanzapine, Haloperidol, or Risperidone Bruce R. Basson, Bruce J. Kinon, Cindy C. Taylor, The Journal of Clinical Psychiatry	2001	281
Long-Term Olanzapine Treatment Bruce J. Kinon, Bruce R. Basson, J. A. Gilmore, The Journal of Clinical Psychiatry Psychotropic MedicationPsychopharmacologyBaseline Body MassindexPharmacotherapySocial Sciences	2001	272
A Multicenter, Inpatient, Phase 2, Double-Blind, Placebo-Controlled Dose-Ranging Study of LY2140023 Monohydrate in Patients With DSM-IV Schizophrenia Bruce J. Kinon, Lu Zhang, Brian A. Millen, Journal of Clinical Psychopharmacology NeuropsychologyActive Control OlanzapinePsychotropic MedicationPsychopharmacologyNeuropsychiatry	2011	254
Early Response to Antipsychotic Drug Therapy as a Clinical Marker of Subsequent Response in the Treatment of Schizophrenia Bruce J. Kinon, Lei Chen, Haya Ascher‐Svanum, Neuropsychopharmacology Subsequent ResponseAntipsychotic Drug TherapyEarly ResponsePsychiatryPsychotic Disorder	2009	175
Exploratory Analysis for a Targeted Patient Population Responsive to the Metabotropic Glutamate 2/3 Receptor Agonist Pomaglumetad Methionil in Schizophrenia Bruce J. Kinon, Brian A. Millen, Lu Zhang, Biological Psychiatry Exploratory AnalysisPsychoactive DrugPsychiatryPsychotic DisorderMedicine	2015	165
Predicting response to atypical antipsychotics based on early response in the treatment of schizophrenia☆ Bruce J. Kinon, Lichang Chen, Haya Ascher‐Svanum, Schizophrenia Research Early ResponsePsychiatryPsychotic DisorderAtypical AntipsychoticsPsychotropic Medication	2008	165
Medication Nonadherence and Treatment Outcome in Patients With Schizophrenia or Schizoaffective Disorder With Suboptimal Prior Response Jean-Pierre Lindenmayer, Hong Liu‐Seifert, Pandurang M. Kulkarni, The Journal of Clinical Psychiatry	2009	161

Page 1